secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2022-05-27T23:59:59+00:00
Accession:  0001801170-22-000034
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health board member Nathaniel Turner resigns; no disagreement cited
--------------------------------------------------------------------------

- Nathaniel S. Turner resigned from the Board of Directors effective May 26, 2022.
- Resignation was not due to any disagreement with the company's operations, policies, or practices.
- Turner served for six years; CEO Vivek Garipalli thanked him for being a driving force in founding Clover.
- No replacement for the vacant board seat has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117022000034/0001801170-22-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117022000034/clov-20220526.htm
  HTML page:      https://secwatch.observer/filing/0001801170-22-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer